As we know that biologicals are an increasing interest for the pharmaceutical companies , especially in the field of oncology, LBS has decided to redesign their Biologicals Simulation. In the past the simulation was focussed on MS, but the new set-up of the course will focus on monoclonal antibodies in the field of oncology. We are working on both an in-life version of this course and an on-line version. It is expected that the first roll-out will be in Q3 2021.
Please visit this website for regular updates.
Interested? Please contact us at email@example.com
Although we had to cancel the in-life courses in 2020 due to Covid-19, LBS has managed to update their courses to on-line versions. If you are interested in the on-lne courses, please view our Calendar.
Due to the Covid-19 crisis, we have not been able to organize in-life courses. However, we have been working (and are still working) on on-line versions of our highly acclaimed courses. The first on-line course that we have provided is the Drug Discovery Simulation for VU Amsterdam students. Although we realize that we need to work on some minor improvements, the general response of the students was very enthousiastic.
LBS is encouraged by the feedback and is now also working on the on-line version of the Drug Development Simulation taking all the feedback on the first on-line simulation into account. We are happy to say that we will be able to offer you the two on-line courses as from January 2021.
LBS is happy to say, that we have decided to have an in-life Drug Development Simulation 7-9 December 2020 in The Netherlands. The location is De Ruwenberg, Sint Michielsgestel. Because of all the COVID restrictions, we have worked with De Ruwenberg to be able to organize this event in a COVID-safe setting.
Interested? Please send us an e-mail on firstname.lastname@example.org.
Today LBS had a shooting day for videos to be used in our new on-line version of the Drug Discovery Simulation. Two professors from the Free University came to explain topics like Target Discovery and Medicinal Chemistry. In addition, we had the assistance of a well experienced Regulatory Affairs expert who discussed the ins-and-outs of a Target Product Profile. Also the CEO of LBS as well as the CEO of our virtual pharmaceutical company, Fellow Pharma, taped their welcome message.
LBS would like to thank all the presenters and the technicians for spending their time and efforts to obtain high quality videos.